Moxetumomab Pasudotox-tdfk and Zohydro ER Capsules
Determining the interaction of Moxetumomab Pasudotox-tdfk and Zohydro ER Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Zoladex
- Moxetumomab Pasudotox-tdfk-Zoladex (Goserelin Implant 10.8 mg)
- Moxetumomab Pasudotox-tdfk-Zoladex (Goserelin Implant 3.6 mg)
- Moxetumomab Pasudotox-tdfk-Zoladex 3-Month
- Moxetumomab Pasudotox-tdfk-Zoladex Implant
- Moxetumomab Pasudotox-tdfk-Zolate
- Zohydro ER Capsules-Moxetumomab pasudotox-tdfk Intravenous
- Zohydro ER Capsules-Moxifloxacin
- Zohydro ER Capsules-Moxifloxacin (Systemic)
- Zohydro ER Capsules-Moxifloxacin Hydrochloride
- Zohydro ER Capsules-Moxifloxacin Injection
- Zohydro ER Capsules-Moxifloxacin Intravenous